HOOKIPA Pharma
HOOK
HOOK was delisted on the 7th of August, 2025.
54 hedge funds and large institutions have $19.2M invested in HOOKIPA Pharma in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 17 reducing their positions, and 7 closing their positions.
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
12% more call options, than puts
Call options by funds: $37K | Put options by funds: $33K
0% more funds holding
Funds holding: 54 → 54 (0)
1% less ownership
Funds ownership: 5.54% → 4.54% (-1%)
12% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 17
50% less capital invested
Capital invested by funds: $38.3M → $19.2M (-$19.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$1.16M |
| 2 |
JFG
Jefferies Financial Group
New York
|
+$1.13M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$618K |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$137K |
| 5 |
Two Sigma Investments
New York
|
+$128K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$4.11M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$2.74M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$1.57M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$152K |
| 5 |
Renaissance Technologies
New York
|
-$114K |
HOOK Hedge Fund Activity: Q4 2022 in Review
54 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q4 2022, worth a combined $19.2M — down 50% from $38.3M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new HOOK positions and 7 closed out — a net gain of 1 holder — while 15 added to existing stakes and 17 trimmed.
The largest buyer was Baker Bros. Advisors, adding an estimated $1.16M. The largest seller was Deep Track Capital, cutting an estimated $4.11M.
- 54 institutional investors held HOOKIPA Pharma (HOOK) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $19.2M of HOOKIPA Pharma stock for Q4 2022, down 50% quarter-over-quarter.
- 8 funds opened new HOOKIPA Pharma positions in Q4 2022 and 7 closed out, a net change of +1 holder.
- The largest HOOKIPA Pharma buyer in Q4 2022 was Baker Bros. Advisors, an estimated $1.16M added.
- The largest HOOKIPA Pharma seller in Q4 2022 was Deep Track Capital, an estimated $4.11M sold.
Based on aggregated 13F filings for Q4 2022.